drugset / Trial / NCT02607670
Phase 2 Study of TAT4 Gel for Reduction of Nasolabial Folds
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a Phase 2, randomized, double-blind, placebo-controlled study of TAT4 Gel for the reduction of moderate to severe nasolabial folds.
Timeline
- Start
- 2016-01
- Primary completion
- 2016-08
- Completion
- 2016-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TAT4 Gel | Unknown | — | Topical |
Indications
No indication recorded.